AI assistant
Sending…
CME GROUP INC. — Director's Dealing 2025
Sep 17, 2025
29871_dirs_2025-09-17_d3980d60-f9bb-48a8-9a9f-8aef2855cb5c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2025-09-15
Reporting Person: Marcus Jonathan L (Sr MD General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-15 | Common Stock Class A | F | 259 | $258.83 | Disposed | 6449 | Direct |
| 2025-09-15 | Common Stock Class A | A | 2464 | $258.83 | Acquired | 8913 | Direct |
| 2025-09-16 | Common Stock Class A | S | 376 | $258.96 | Disposed | 8537 | Direct |
| 2025-09-16 | Common Stock Class A | F | 294 | $259.83 | Disposed | 8243 | Direct |
Footnotes
F1: Mr. Marcus surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2025.
F2: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025.
F3: Mr. Marcus surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.
More from CME GROUP INC.
Proxy Solicitation & Information Statement
2026
May 19
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
Apr 24
Earnings Release
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Remuneration Information
2026
Mar 23
Annual Report
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17